Search results

64 items matching your search terms.
Filter the results.
Item type













New items since



Sort by relevance · date (newest first) · alphabetically
Partnerships, cancer research in Malawi to expand with new grant
UNC Lineberger Comprehensive Cancer Center and the UNC Institute for Global Health & Infectious Diseases have received a $3.7 million grant from the National Cancer Institute (NCI) to study the growing worldwide cancer problem and expand the University’s efforts in Malawi to study and treat HIV-associated cancers.
Located in Vital Signs / 2014 / Oct. 30
Mending Hearts in Nicaragua
In February, three UNC interventional cardiologists and a team of dedicated health care professionals travelled to Nicaragua to perform a life-saving, minimally invasive procedure on as many patients as they could, and to bring the best in cardiac care to a country without heart surgeons.
Located in News / 2017 / May
Fischer on Ebola
West Africa continues to experience a deadly Ebola virus outbreak. In May/June, Dr. William Fischer II, a pulmonologist and critical care physician with the UNC School of Medicine, worked in an isolation area in Guinea as part of a team from Doctors without Borders after being recruited by the World Health Organization. To raise awareness about the crisis, we have gathered a list of his media appearances for your viewing.
Located in Vital Signs / 2014 / July 31
UNC medical students gain invaluable experiences abroad
Through the Office of International Activities at the UNC School of Medicine, approximately one-third of UNC medical students experience international health electives during their time in Chapel Hill. This past summer nearly 50 students traveled abroad to research, teach, and enhance their clinical skills while serving underserved populations. The experiences provided students with invaluable insights and encouraged some to continue to make international work part of their lives and careers. Last week students shared their experiences via the UNC SOM Facebook page. Please take a moment to view this visual recap of where our students went and read what they had to say. And if you haven't already done so, "Like" the UNC School of Medicine on Facebook.
Located in Vital Signs / 2015 / Sept. 3
Long-acting injectable implant shows promise for HIV treatment and prevention
The long-acting antiretroviral drug formulation, developed by UNC School of Medicine researchers Rahima Benhabbour, PhD and Martina Kovarova, PhD, is injected under the skin and forms into a solid implant that dissolves slowly to release anti-HIV medication over time.
Located in News / 2018 / October
UNC receives $8 million grant to improve safe motherhood in Malawi
The University of North Carolina at Chapel Hill has received a five-year, $8 million grant from the Bill & Melinda Gates Foundation to improve maternal and infant health and save the lives of mothers and infants in Malawi by strengthening the President’s Maternal Health and Safe Motherhood Initiative (SMI).
Located in News / 2013 / July
UNC to Test Therapeutic Vaccine in People Living with HIV
A multidisciplinary research team at the University of North Carolina at Chapel Hill has been awarded more than $5.6 million from the National Institutes of Health (NIH) to test a therapeutic vaccine in people living with HIV.
Located in Vital Signs / 2017 / July 27
Vorinostat Renders Dormant HIV Infection Vulnerable to Clearance
The ability for HIV to hide in the body in a dormant state makes curing the 40 million people living with the virus a challenge. Researchers at the University of North Carolina at Chapel Hill have shown the drug Vorinostat reverses this latency, causing resting CD4 T-cells to express HIV.
Located in Vital Signs / 2017 / Aug. 3
Anemia protects African children against Malaria
UNC researchers have proven these concerns valid after finding iron deficiency anemia actually protects children against the blood-stage of Plasmodium falciparum malaria in Africa, and treating anemia with iron supplementation removes this protective effect. Morgan Goheen, PhD, is the study's lead author.
Located in Vital Signs / 2017 / Jan. 12
Ebola Detected in Semen of Survivors Two Years after Infection
Ebola virus RNA can persist in the semen of survivors more than two years after the onset of infection researchers at the University of North Carolina at Chapel Hill have found.
Located in Vital Signs / 2017 / Aug. 3